Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-29

FDA Approved: REMERONSOLTAB — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for REMERONSOLTAB (mirtazapine) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REMERONSOLTAB (Mirtazapine)

Snippet

SUPPL AP for REMERONSOLTAB (MIRTAZAPINE)